Super-early images of brain perfusion SPECT using 123I-IMP for the assessment of hyperperfusion in stroke patients
With the advancement of reperfusion therapy in stroke patients, assessment of perfusion status after therapy is gaining importance. Hyperperfusion tends to be underestimated by the conventional early imaging of 123I-IMP brain perfusion SPECT. We evaluated the utility of super-early imaging as an adjunct to early imaging for the assessment of postischemic hyperperfusion in stroke patients.
Sixty-seven patients who underwent 123I-IMP brain perfusion SPECT within 14 days after the onset of cerebral infarction were retrospectively analyzed. Super-early (4–10 min) and early (15–45 min) images were acquired using a dual-headed gamma camera. Postischemic hyperperfusion was visually assessed using the early images alone and then using both the super-early and early images, and the frequency of postischemic hyperperfusion and the confidence level of the judgement were evaluated. For quantitative evaluation of image contrast, the contrast ratios (the count ratios of the hyperperfused to normal areas) were calculated.
The frequency of postischemic hyperperfusion was significantly higher using both the super-early and early images (28/67 patients) than using the early images alone (17/67 patients, p < 0.001). In 56 patients in whom judgement regarding the presence or absence of postischemic hyperperfusion was unchanged, the confidence level was increased in 8 patients using both image sets. The addition of the super-early SPECT images was judged to be useful and marginally useful in 14 and 15 patients, respectively. The contrast ratio was significantly higher on the super-early images (1.48 ± 0.25) than on the early images (1.26 ± 0.18, p < 0.001).
The addition of super-early imaging to the conventional early imaging aids assessment of postischemic hyperperfusion by 123I-IMP brain perfusion SPECT and may contribute to management of stroke patients in the era of reperfusion therapy.
KeywordsSPECT 123I-IMP Hyperperfusion Stroke
Compliance with ethical standards
Conflict of interest
There is no conflict of interest in relation to this study.
- 4.Abumiya T, Katoh M, Moriwaki T, Yoshino M, Aoki T, Imamura H, et al. Utility of early post-treatment single-photon emission computed tomography imaging to predict outcome in stroke patients treated with intravenous tissue plasminogen activator. Stroke Cerebrovasc Dis. 2014;23:896–901.CrossRefGoogle Scholar
- 13.Yonekura Y, Nishizawa S, Mukai T, Iwasaki Y, Fukuyama H, Ishikawa M, et al. Functional mapping of flow and back-diffusion rate of N-isopropyl-p-iodoamphetamine in human brain. Nucl Med. 1993;34:839–44.Google Scholar
- 20.Lassen NA, Sperling B. 99mTc-bicisate reliably images CBF in chronic brain diseases but fails to show reflow hyperemia in subacute stroke: report of a multicenter trial of 105 cases comparing 133Xe and 99mTc-bicisate (ECD, neurolite) measured by SPECT on same day. J Cereb Blood Flow Metab. 1994;14(Suppl 1):44–8.Google Scholar